Hycor Biomedical, Inc.

Hycor Biomedical, Inc.

Hycor Biomedical, Inc.

Overview
Date Founded

1981

Headquarters

3021 East 98th Street,Suite 220,Indianapolis, IN 46240

Type of Company

Private

Employees (Worldwide)

101 - 250

Industries

Pharmaceuticals
Biotechnology
Hospitals & Patient Services
Medical Products & Equipment

Company Description

HYCOR Biomedical, Inc. manufactures in vitro diagnostic products for allergy and autoimmune testing. The firm's products include allergy testing, autoimmune testing, HYTEC 288 plus and HCOR ultra-sensitive EIA. It markets the HYTEC, KOVA and AUTOSTAT brands. The company was founded in 1981 and is headquartered in Garden Grove, CA.

Contact Data
Trying to get in touch with decision makers at Hycor Biomedical, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Operating Officer

Chief Executive Officer & Chairwoman

Director, Human Resources

Vice President & General Manager, EMEA

Senior Vice President, Commercial Operations

Vice President of Operations, Quality Assurance & Regulatory Affairs

Vice President-Research & Development

Vice President, Global Commercial Operations

Vice President of Regulatory, Quality & Clinical Affairs

Vice President of Operations

Board of Directors

Chairman & Chief Executive Officer at Rubicon Genomics, Inc.

Member at New York Angels, Inc.

Paths to Hycor Biomedical, Inc.
Potential Connections via
Relationship Science
You
Hycor Biomedical, Inc.
Transaction Advisors
Accountant

Advised onHycor Biomedical, Inc. purchases Cogent Diagnostics Ltd

Investment Advisor

Advised onHycor Biomedical, Inc. /Urinalysis Bus/Private Group purchases Kova International, Inc. from Linden Manager LLC

Legal Advisor

Advised onHycor Biomedical, Inc. /Urinalysis Bus/Private Group purchases Kova International, Inc. from Linden Manager LLC

Non-Profit Donations & Grants
Investors
Details Hidden

Linden invests in mature healthcare and life sciences companies including those involved in animal health products, behavioral health, dental, diagnostics, food safety, healthcare & life science contract manufacturing, healthcare services, hospital products, infection control, life science equipment and consumables, nutraceuticals, oral care, physical rehabilitation, specialty chemicals and reagents, specialty pharmaceuticals, sterilization/infection control and wound care.The firm participates in (1) control-oriented LBOs of privately held businesses, corporate divisions or public companies (2) restructuring/recapitalizations of privately held businesses (3) staged transitions of corporate-owned entities (4) partnerships with other strategic or financial buyers and (5) going private transactions. Linden does not make venture capital investments.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hycor Biomedical, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hycor Biomedical, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Hycor Biomedical, Inc..